---
title: Elephas Early Access Program
description: Elephas has developed a functional ex vivo platform that measures cytokine response in live tumor biopsies following treatment with a therapeutic agent.
image: https://elephas.com/hubfs/2025/Website/AdobeStock_437278860.jpeg
---

[![Elephas](https://elephas.com/hubfs/raw_assets/public/ele_2024/images/ele-logo-white-r.svg)](https://elephas.com/?hsLang=en)

Menu

×

- Technology 
    - [What We Do](https://elephas.com/what-we-do?hsLang=en)
    - [In Development](https://elephas.com/product-development?hsLang=en)
    - [FAQs](https://elephas.com/faqs?hsLang=en)
- Products & Services 
    - [Elephas Labs](https://www.elephaslabs.com/?hsLang=en)
    - [Pharma Services](https://elephas.com/products-services-pharma?hsLang=en)
    - [Research](https://elephas.com/products-services/research?hsLang=en)
- Resources 
    - [Publications](https://elephas.com/resources/publications?hsLang=en)
    - [Clinical Trials](https://elephas.com/resources/clinical-trials?hsLang=en)
    - [Content](https://elephas.com/resources/content?hsLang=en)
    - [Documents](https://elephas.com/resources/documents?hsLang=en)
- About Elephas 
    - [About Us](https://elephas.com/about-us?hsLang=en)
    - [Careers](https://elephas.com/careers?hsLang=en)
    - [International Partnerships](https://elephas.com/international-partnerships?hsLang=en)
    - [Get In Touch](https://elephas.com/get-in-touch?hsLang=en)
    - [FAQs](https://elephas.com/faqs?hsLang=en)
    - [News](https://elephas.com/news?hsLang=en)

# Early Access Program

- [Home](https://elephas.com/?hsLang=en)

## Help us change the way your patients receive immunotherapy

#### elive™ Test  is now available to clinicians for research use under the Early Access Program

Select clinicians are now eligible for early access to  elive™ Test under Elephas research and development programs. Support our mission to improve the lives of cancer patients by providing valuable data and feedback on your patients’ cancer care.

Early access to elive™ Test reports is provided for research use only (RUO).

Take the next step and contact us.

[ Contact Us ](https://elephas.com/products-services/early-access-program#eap-form)

![Pipetting under the BSC (Biological Safety Cabinet)](https://elephas.com/hs-fs/hubfs/2026/Corp%20Website/Images/Pipetting%20under%20the%20BSC%20(Biological%20Safety%20Cabinet).jpg?width=2000&name=Pipetting%20under%20the%20BSC%20(Biological%20Safety%20Cabinet).jpg)

### More about the Early Access Program:

-  elive™ Test must be ordered by a licensed U.S. healthcare provider.
- Available to patients with suspected or confirmed solid tumor, who are candidates for ICI therapy and eligible for core needle biopsy.
- Patients and providers willing to provide diagnosis, treatment, and clinical follow-up data to support Elephas’ research and development programs.
- Early access RUO testing with elive™ Test is not eligible for reimbursement. Patient and provider will not be billed for the RUO test.
- Program participation and availability may be limited.

## What's new at Elephas

![poster-KO](https://elephas.com/hubfs/2025/Icons/poster-KO.svg)

**Clinical validation of the Elephas Live Platform presented at SITC 2025**

[ Read more ](https://elephas.com/hubfs/2026/20251104_SITC+Poster.pdf?hsLang=en)

![publication-KO](https://elephas.com/hubfs/2025/Icons/publication-KO.svg)

###### Overview of an ex vivo platform to assess immunotherapy response in Journal of Translational Medicine

[ Learn More ](https://link.springer.com/article/10.1186/s12967-025-07378-2)

![poster-KO](https://elephas.com/hubfs/2025/Icons/poster-KO.svg)

**See data from our clinical trials in our ASCO 2025 poster.**

[ Learn more ](https://elephas.com/hubfs/2026/20250512_TIP_ASCO_Poster_Draft%20(1)%20(1).pdf?hsLang=en)

## Ready to get into the details?

Contact us to request more information about the Elephas early access program for elive™ Test. 

Early access to elive™ Test reports is provided for research use only (RUO).

![elephas](https://elephas.com/hubfs/raw_assets/public/ele_2024/images/ele-logo-white-r.svg)

- [About Us](https://elephas.com/about-us)
- [Careers](https://elephas.com/careers)
- [Get In Touch](https://elephas.com/get-in-touch)
- [FAQs](https://elephas.com/faqs)
- [What We Do](https://elephas.com/what-we-do)
- [Publications](https://elephas.com/resources/publications)
- [Trust Center](https://trustcenter.elephas.com/)
- [Privacy Policies](https://elephas.com/privacy-policies)
- [Terms of Service](https://elephas.com/terms-of-service)

##### Follow us on

<https://www.linkedin.com/company/elephasbiosciences/>

Elephas Biosciences Corporation • 1 Erdman Pl, Suite 100, Madison, WI 53717, United States

©2026 Elephas - All rights reserved  
For Research Use Only - Not for use in diagnostic procedures

Cookie Settings

### National Advisory Group

![Pooja Advani](https://elephas.com/hs-fs/hubfs/content_2024/headshots/Pooja_Advani.webp?width=174&name=Pooja_Advani.webp)

**Pooja Advani,   
MBBD, MD**  
Medical Oncologist  
Breast Cancer  
**Mayo Clinic**

![David Braun](https://elephas.com/hs-fs/hubfs/content_2024/headshots/David_Braun.webp?width=174&name=David_Braun.webp)

**David Braun,   
MD, PhD**  
Medical Oncologist  
Kidney Cancer  
**Yale School of Medicine**

![Christian Capitini](https://elephas.com/hs-fs/hubfs/content_2024/headshots/Christian_Capitini.webp?width=174&name=Christian_Capitini.webp)

**Christian Capitini, MD**  
Director  
**UW Health | Carbone Cancer Center**

![Kevin Eliceiri](https://elephas.com/hs-fs/hubfs/content_2024/headshots/Kevin_Eliceiri.webp?width=174&name=Kevin_Eliceiri.webp)

**Kevin Eliceiri, PhD**  
Professor of Microscopy, Medical Imaging & AI  
**The University of Wisconsin-Madison**

![Janis_Marie_Taube](https://elephas.com/hs-fs/hubfs/content_2024/headshots/Janis_Marie_Taube.webp?width=174&name=Janis_Marie_Taube.webp)

**Janis Marie Taube,   
MD, MSc**  
Pathologist  
Melanoma  
**Johns Hopkins Medicine**

![](https://elephas.com/hubfs/content_2024/purple-bg.webp) ![](https://elephas.com/hubfs/content_2024/navy-bg.webp)